New, Open-Access Tool Guides Pediatric Amblyopia Diagnosis, Management

Follow Drugslib on

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on June 2, 2026.

via HealthDay

TUESDAY, June 2, 2026 -- A new decision support tool can assist optometrists and ophthalmologists in the care of children aged 3 to 17 years with amblyopia, according to a special communication published online May 7 in JAMA Ophthalmology.

Allison I. Summers, O.D., from Oregon Health & Science University in Portland, and colleagues from the Pediatric Eye Disease Investigator Group, conducted a literature search and incorporated consensus opinion to create the Amblyopia Navigator Decision-Support Instrument (ANDI), a free, web-based amblyopia decision support tool for eye care professionals.

Based on 147 publications and additional professional guidelines, the ANDI tool is designed to guide any eye doctor through the diagnosis of amblyopia and subsequent management options. The tool helps the eye care clinician without specialty training in pediatric eye care to determine the best glasses prescription for the patient based on a few clinical findings. The tool also helps assess how long to monitor whether glasses alone are improving vision, or if glasses are not enough, ANDI walks the clinician through next steps, including patching the stronger eye for a couple of hours a day, using atropine eye drops to temporarily blur the stronger eye, or considering newer digital treatments delivered through specially designed games or videos. The tool also provides steps for follow-up visits, signs of stalled progress or recurrence, and recommendations for changing the course of treatment and when to refer to a specialist. The tool can be used at an initial visit or along the amblyopia care journey.

"We hope that this tool can be leveraged to minimize gaps in access to pediatric ophthalmic care," coauthor Stacy L. Pineles, M.D., cochair of the Pediatric Eye Disease Investigator Group, said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-06-03 03:42

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords